Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 10, 2019

SELL
$3.51 - $4.77 $4.84 Million - $6.58 Million
-1,379,938 Reduced 84.52%
252,708 $1 Million
Q4 2018

Feb 06, 2019

SELL
$3.87 - $7.11 $2.72 Million - $5 Million
-703,343 Reduced 30.11%
1,632,646 $6.5 Million
Q3 2018

Nov 08, 2018

BUY
$5.42 - $6.99 $90,698 - $116,970
16,734 Added 0.72%
2,335,989 $16.1 Million
Q2 2018

Aug 02, 2018

BUY
$5.99 - $8.17 $158,752 - $216,529
26,503 Added 1.16%
2,319,255 $15.7 Million
Q1 2018

Apr 20, 2018

BUY
$4.66 - $7.08 $1.39 Million - $2.11 Million
297,984 Added 14.94%
2,292,752 $14.9 Million
Q4 2017

Jan 25, 2018

BUY
$3.73 - $6.37 $75,092 - $128,240
20,132 Added 1.02%
1,994,768 $8.88 Million
Q3 2017

Nov 03, 2017

BUY
$5.28 - $6.88 $10.4 Million - $13.6 Million
1,974,636
1,974,636 $12.2 Million

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $668M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Jennison Associates LLC Portfolio

Follow Jennison Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.